Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Kristina M. Utzschneider(VA Puget Sound Health Care System), E. Gonzalez Hattery, S. Behringer-Massera, T.S. Raines, Anders L. Carlson, A. Ross, C.A. White, J. Brown-Friday, M.R. Gramzinski(Milken Institute), H. Estrella, S. Duran, Ashok Balasubramanyam, Tasma Harindhanavudhi(University of Minnesota), M. Sibymon, L. Holloway, Ruchi Gaba, William I. Sivitz(University of Iowa), Richard M. Bergenstal(HealthPartners), E. Xhori, L. Savoye, Nicole M. Butera(Milken Institute), Philip Wilson(University of Copenhagen), M. Diane McKee(Albert Einstein College of Medicine), J. Lukin, Alexandra Kozedub(The Coordinating Center), J.P. Crandall, F. Morehead, Elizabeth Burgess, Samuel P. Rosin(Milken Institute), K. Ballentine-Cargill, Cynthia Adams, A. Balasubramanyam, R. Mungara, L.S. Phillips, Ralph A. DeFronzo(The University of Texas at San Antonio Health Science Center), M. Rhee, S. Gonzalez de la torre, N.M. Brown(State University of New York), Mark Tripputi(George Washington University), Neda Rasouli(Tufts University), M. Maher-Albertelli, S. Person, Mary Ann Banerji(State University of New York), C. Gullett, Andrea Mari(National Research Council), Michael W. Steffes(University of Minnesota), J. Boers, S. Tanukonda, Darin E. Olson(Emory University), J. Costello
Cited by 2
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
|Diabetes|2009|3k
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
|Diabetes Care|2009|2.1k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.
|Journal of Clinical Investigation|1985|1.2k